01—Abstract
Summary
Summary of the 8-K filed September 11, 2025. Cited figures are marked; the original filing is the authoritative source.
Centene Corporation (CNC) announced via an 8-K filing on September 11, 2025, that management will participate in the Deutsche Bank 2025 Healthcare Summit.
During this presentation, the company reiterated its full-year 2025 adjusted diluted earnings per share (EPS) forecast of approximately $1.75a. This confirms that current business performance through August is tracking in line with the company's prior guidance, providing a degree of stability for investors amidst ongoing market dynamics. The filing also provided context on the use of non-GAAP financial measures, emphasizing their utility in assessing ongoing operational performance and consistency across periods.
While not providing specific reconciliations for the EPS forecast to GAAP measures, Centene highlighted that these non-GAAP figures, excluding items like amortization of acquired intangibles and acquisition-related expenses, offer a clearer view of core business operations. Investors are encouraged to review the full GAAP financial statements alongside these non-GAAP metrics.
02—Key points
Key Highlights
- Centene Corporation reiterates its full-year 2025 adjusted diluted EPS forecast of approximately $1.75.
- Company performance through August is consistent with the previously issued full-year guidance.
- Management will present at the Deutsche Bank 2025 Healthcare Summit on September 11, 2025.
- A live audio webcast and replay of the presentation will be available on Centene's website.
- The company utilizes non-GAAP financial measures to provide insight into ongoing operational performance and consistency.
- Non-GAAP measures exclude items such as amortization of acquired intangible assets and acquisition/divestiture related expenses.
- Investors are advised to consider non-GAAP measures in conjunction with, and not as a substitute for, GAAP financial information.
03—Questions
Frequently Asked Questions
What is the main purpose of this 8-K filing?
The primary purpose of this 8-K filing is to inform investors that Centene Corporation management will be participating in the Deutsche Bank 2025 Healthcare Summit and to reiterate the company's previously issued full-year 2025 adjusted diluted EPS forecast.
Is Centene changing its financial outlook for 2025?
No, the filing indicates that Centene's business and financial results through August are consistent with its previously issued full-year 2025 forecast of approximately $1.75 adjusted diluted EPS. This suggests no change to the existing guidance.
What is the significance of the non-GAAP financial measures mentioned?
Centene uses non-GAAP financial measures, such as adjusted diluted EPS, to offer investors a clearer view of the ongoing nature of its operations and to measure performance more consistently across periods. These measures exclude certain items like amortization of acquired intangible assets and acquisition-related expenses, which are believed to provide a better understanding of the company's core business performance.
Where can I find the presentation from the Deutsche Bank Healthcare Summit?
A live audio webcast of the presentation will be available during the event on September 11, 2025. Following the presentation, a webcast replay will be accessible on Centene's website, www.centene.com, in the Investors section.
04—Continue